Summary Background The cardiovascular-kidney-liver-metabolic (CKLM) framework represents the multi-organ interplay of systemic metabolic disorders that drive the global burden of cardiovascular diseases (CVD). Methods This study is a descriptive epidemiological analysis of the Global Burden of Disease Study 2023 that e...
J. Jayabaskaran, Haryo Raden Himan, S. Nagarajan et al.· EClinicalMedicine· 0 citations
A higher CKM stage is associated with an increased long-term risk of MACEs and LREs across the SLD spectrum, and obesity and hypertension are the primary contributors to both outcomes, and diabetes additionally contributes to LREs.
Qiong-Yue Fan, Li-You Lian, Tian-Yi Xia et al.· i Medicina· 0 citations
Individuals with MASLD who experience a CVD event have a higher subsequent risk of long-term LREs, and the value of targeted liver monitoring for high-risk individuals after CVD and integrated heart-liver co-management is underscored.
Li-You Lian, Qin-Fen Chen, Tianyi Xia et al.· Metabolism: Clinical and Exp...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.